Drug Information

Drug General Information
Drug ID
D0N2NI
Drug Name
Entrectinib
Indication Mammary analogue secretory carcinoma [ICD10:C07] Phase 1 [1572606]
Colorectal cancer [ICD10:C18-C21] Phase 1 [1572606]
Drug Resistance Mutation (DRM)
DRM DRM Info
References
Ref 1572606Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.